Search | IOVS | ARVO Journals

View

Showing 1 – 7 of 7

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

ADX-103, a Novel Small Molecule Aldehyde Sequestering Agent, Decreases Retinal Edema and Inflammation in a Rat Model of Diabetic Macular Edema

Adna Halilovic; Todd Brady; Susan Macdonald

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):198. doi:

ARVO Annual Meeting Abstract July 2018

A Randomized, Double-Masked, Parallel-Group, Phase 2a Dry Eye Disease Clinical Trial to Evaluate the Safety and Efficacy of Topical Ocular ADX-102, a Novel Aldehyde Sequestering Agent

David Clark; George W Ousler; David Hollander; Todd Brady

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1967. doi:

ARVO Annual Meeting Abstract July 2018

Novel Small Molecule Aldehyde Sequestering Agents Demonstrate Broad Therapeutic Potential for Ocular Inflammation

Susan Macdonald; Adna Halilovic; Todd Brady

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2663. doi:

ARVO Annual Meeting Abstract July 2018

A Randomized, Multi-Center, Double-Masked, Vehicle-Controlled, Parallel-Group Phase 2b Allergic Conjunctivitis Clinical Trial of Topical Ocular ADX-102, a Novel Aldehyde Sequestering Agent

Paul J Gomes; Todd Brady; David Hollander; David Clark

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5571. doi:

ARVO Annual Meeting Abstract June 2017

A Randomized, Comparator-Controlled Phase 2 Clinical Trial of ADX-102 Ophthalmic Solution in Noninfectious Anterior Uveitis

John D Sheppard; Todd Brady; C. Stephen Foster; Kenneth J Mandell; Scott L Young

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1231. doi:

ARVO Annual Meeting Abstract June 2015

The Aldehyde Trap NS2 Mitigates Dense Haze in a Rabbit Model of Photorefractive Keratectomy

Daniel J Gibson; Kenneth J. Mandell; Scott L. Young; Todd C Brady

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3931. doi:

ARVO Annual Meeting Abstract June 2015

The Aldehyde Trap NS2 Reduces Ocular Inflammation in an Endotoxin-Induced Model in Rats

Kenneth J Mandell; Scott L Young; Todd C Brady

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3095. doi:

Advertisement